Showing 1 - 4 results of 4 for search 'Bower, L', query time: 0.02s
Refine Results
-
1
The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic by Frankell, AM, Jammula, S, Li, X, Contino, G, Killcoyne, S, Abbas, S, Perner, J, Bower, L, Devonshire, G, Ococks, E, Grehan, N, Mok, J, O'Donovan, M, Macrae, S, Eldridge, MD, Tavaré, S, Oesophageal Cancer Clinical And Molecular Stratification (OCCAMS) Consortium, Fitzgerald, RC, Crichton, C
Published 2019Journal article -
2
A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy by Noorani, A, Bornschein, J, Lynch, A, Secrier, M, Achilleos, A, Eldridge, M, Bower, L, Weaver, J, Crawte, J, Ong, C, Shannon, N, Macrae, S, Grehan, N, Nutzinger, B, O'Donovan, M, Hardwick, R, Tavaré, S, Fitzgerald, R, Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium
Published 2017Journal article -
3
Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics by Li, X, Francies, H, Secrier, M, Perner, J, Miremadi, A, Galeano-Dalmau, N, Barendt, W, Letchford, L, Leyden, G, Goffin, E, Barthorpe, A, Lightfoot, H, Chen, E, Gilbert, J, Noorani, A, Devonshire, G, Bower, L, Grantham, A, Macrae, S, Grehan, N, Wedge, D, Fitzgerald, R, Garnett, M
Published 2018Journal article -
4
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance by Secrier, M, Li, X, De Silva, N, Eldridge, MD, Contino, G, Bornschein, J, Macrae, S, Grehan, N, O'Donovan, M, Miremadi, A, Yang, T-P, Bower, L, Chettouh, H, Crawte, J, Galeano-Dalmau, N, Grabowska, A, Saunders, J, Underwood, T, Waddell, N, Barbour, AP, Nutzinger, B, Achilleos, A, Edwards, PAW, Lynch, AG, Tavaré, S, Fitzgerald, RC, Oesophageal Cancer Clinical And Molecular Stratification (Occams) Consortium
Published 2016Journal article